Post-Marketing Surveillance of Lenvima in Korean Patients
The purpose of this post-marketing surveillance (PMS) is to observe the safety profile of Lenvima (lenvatinib) in normal clinical practice setting.
Differentiated Thyroid Carcinoma (DTC)
Number of Participants with Adverse Events, Serious Adverse Events, and Adverse Drug Reactions, Up to 1 year
The purpose of this post-marketing surveillance (PMS) is to observe the safety profile of Lenvima (lenvatinib) in normal clinical practice setting.